全球價值型醫療保健市場

預計到 2030 年全球基於價值的醫療保健市場規模將達到 251 億美元

全球價值型醫療保健市場規模預計在2024年為101億美元，預計到2030年將達到251億美元，2024年至2030年的複合年成長率為16.4%。報告中分析的細分領域之一——按績效付費——預計複合年成長率為15.3%，到分析期結束時規模將達到58億美元。以患者為中心的家庭醫療細分領域在分析期間的複合年成長率預計為14.0%。

美國市場預計將達到 28 億美元，中國市場複合年成長率將達到 21.4%

美國醫療保健市場規模預計在2024年達到28億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到54億美元，在2024-2030年的分析期間內，複合年成長率為21.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為12.2%和14.6%。在歐洲，預計德國市場的複合年成長率約為13.0%。

全球基於價值的醫療保健市場—主要趨勢和促進因素摘要

傳統醫療模式為何轉向以價值為基礎的醫療

全球醫療保健產業正在經歷重大變革時期，從基於數量的模式（即醫療服務提供者按服務收費）轉向基於價值的醫療保健（VBHC），即報酬與患者治療結果和護理品質掛鉤。這種轉變是由不永續的醫療成本上漲、醫療服務分散以及按服務收費系統中病患治療結果不佳所驅動的。基於價值的醫療保健透過獎勵醫療服務提供者的效率、協作和可衡量的健康改善（而非提供的服務量）來重新調整激勵機制。包括私人保險公司和公共衛生系統在內的支付方擴大採用獎勵支付、共用儲蓄計劃和基於結果的合約來追究醫療服務提供者的責任。慢性病的流行、人口老化以及能夠實現結果追蹤和風險分層的數位化進步也推動了這項變革。 VBHC 透過個人化的照護途徑賦能患者，增強醫療服務提供者的課責，並提高系統效率，使其成為全球下一代醫療改革努力的關鍵。

數位科技如何推動基於價值的醫療保健的興起？

技術是基於價值的醫療保健的支柱，它能夠實現即時數據共用、結果衡量和大規模病人參與。電子健康記錄(EHR)、遠端醫療和行動醫療應用程式已成為促進協作、持續和數據驅動護理的重要工具。進階分析平台利用巨量資料來預測患者風險、監測慢性病進展和製定個人化治療計劃。人工智慧 (AI) 正被用於分析大量臨床和索賠數據、識別護理差距並推薦循證干預措施。遠端患者監護(RPM) 設備可實現主動護理管理，特別是對於患有糖尿病、高血壓和心臟衰竭的高風險患者。醫療 IT 系統之間的互通性也在提高，使多個相關人員（醫院、付款人、基層醫療醫師和專家）更容易有效地合作。這種數位化能力不僅支持提高護理質量，還使基於績效的支付模式在不同的醫療保健系統中變得可行和可擴展。

相關人員的合作和政策改革能否增強採用率？

向價值導向型醫療保健的轉變取決於各相關人員——政府、付款人、醫療服務提供者、製藥公司和患者——能否圍繞通用的健康目標攜手合作。政策制定者在製定支持價值導向型醫療保健（VBHC）的法規和獎勵方面發揮關鍵作用。在美國，醫療保險共享儲蓄計劃和責任醫療組織 (ACO) 等舉措已在降低成本和提高品質方面取得了初步成功。同樣，瑞典、荷蘭和新加坡等國家也將 VBHC 原則納入其國家衛生策略。製藥和醫療設備公司也在採用價值導向合約，將報銷與實際結果而非銷售量掛鉤。雇主和保險公司正在推動針對目標族群的基於結果的醫療保健，以管理長期成本。患者權益倡導日益增強，他們要求透明度、個人化護理和可衡量的結果。教育、建立信任和數據透明度對於克服阻力並將價值導向框架確立為常態而非利基市場仍然至關重要。

是什麼推動了基於價值的醫療保健市場的成長？

價值型醫療保健市場的成長受到多種因素的驅動，這些因素根源於醫療體系效率低下、支付方創新以及患者期望的不斷變化。不斷上漲的醫療成本與患者療效的改善並不相稱，這迫使相關人員尋求更永續、與績效掛鉤的醫療模式。慢性病和多重疾病的普遍存在需要縱向協調的護理，而價值型醫療保健框架 (VBHC) 可以更好地支持這種模式。數位醫療技術的普及使得準確衡量健康結果和成本指標成為可能，從而使價值型醫療報銷成為現實。雇主和私人支付方正在倡導注重預防性護理和長期健康結果的價值型保險設計，從而推動支付方的需求。同時，越來越多的患者正在加入「病人歷程」，並期望 VBHC 能夠提供所有服務，包括成本透明度、治療有效性和個人化體驗。政府改革和世界衛生組織 (World Health Initiative )正在透過政策支持、試點計畫和共用國際最佳實踐，進一步將價值型醫療方法制度化。隨著這項運動的發展勢頭強勁，VBHC 正在從理論模型轉變為重新定義全球醫療保健服務的主導範式。

部分

模型（論績效計酬、以病人為中心的家庭醫療、共享儲蓄、共擔風險、捆綁支付、人頭稅模型）、付款人（醫療保險和醫療保險優勢計劃、醫療補助、商業）、提供者（家庭醫療保健、機構護理、自我護理、醫院治療）

受訪公司範例（43家值得關注的公司）

• Aetna Inc.
• Anthem, Inc.
• Athenahealth
• Baker Tilly US, LLP
• Better Health Group
• Blue Cross and Blue Shield of Minnesota
• Cardinal Health
• Change Healthcare
• Cigna Healthcare
• Curation Health
• Deloitte
• Humana
• Kaiser Permanente
• Lumeris
• McKesson Corporation
• MVP Health Care
• Navvis Healthcare
• NXGN Management, LLC
• Signify Health, Inc.
• UnitedHealth Group

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 比賽

Global Value-based Healthcare Market to Reach US$25.1 Billion by 2030

The global market for Value-based Healthcare estimated at US$10.1 Billion in the year 2024, is expected to reach US$25.1 Billion by 2030, growing at a CAGR of 16.4% over the analysis period 2024-2030. Pay for Performance, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$5.8 Billion by the end of the analysis period. Growth in the Patient-centered Medical Home segment is estimated at 14.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 21.4% CAGR

The Value-based Healthcare market in the U.S. is estimated at US$2.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.4 Billion by the year 2030 trailing a CAGR of 21.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.2% and 14.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global "Value-Based Healthcare" Market - Key Trends & Drivers Summarized

Why Is the Traditional Healthcare Model Giving Way to Value-Based Care?

The global healthcare industry is undergoing a significant transformation, pivoting away from volume-based models-where providers are paid per service-to value-based healthcare (VBHC), where payments are linked to patient outcomes and care quality. This shift is driven by the unsustainable rise in healthcare costs, fragmented care delivery, and suboptimal patient outcomes in fee-for-service systems. Value-based care realigns incentives by rewarding providers for efficiency, coordination, and measurable health improvements rather than the sheer quantity of services delivered. Payers, including private insurers and public health systems, are increasingly adopting bundled payments, shared savings programs, and outcome-based contracts to hold providers accountable. This evolution is also spurred by chronic disease prevalence, aging populations, and digital advancements that enable outcome tracking and risk stratification. VBHC empowers patients through personalized care pathways, enhances provider accountability, and fosters systemic efficiency, making it a cornerstone of next-generation healthcare reform efforts worldwide.

How Are Digital Technologies Enabling the Rise of Value-Based Healthcare?

Technology is the backbone of value-based healthcare, enabling real-time data sharing, outcome measurement, and patient engagement at scale. Electronic health records (EHRs), telemedicine, and mobile health applications have become essential tools in facilitating coordinated, continuous, and data-driven care. Advanced analytics platforms leverage big data to predict patient risk, monitor chronic disease progression, and personalize treatment plans. Artificial intelligence (AI) is being used to analyze large volumes of clinical and claims data, identify care gaps, and recommend evidence-based interventions. Remote patient monitoring (RPM) devices allow for proactive care management, particularly for high-risk patients with conditions like diabetes, hypertension, and heart failure. Interoperability among health IT systems is also improving, making it easier for multiple stakeholders-hospitals, payers, primary care physicians, and specialists-to collaborate effectively. These digital capabilities not only support care quality improvement but also make performance-based payment models viable and scalable across diverse healthcare systems.

Can Stakeholder Alignment and Policy Reform Drive Widespread Adoption?

The transition to value-based healthcare hinges on the collective alignment of diverse stakeholders-governments, payers, providers, pharmaceutical companies, and patients-toward shared health goals. Policymakers are playing a critical role by enacting regulations and incentives that support VBHC adoption. In the U.S., initiatives like the Medicare Shared Savings Program and Accountable Care Organizations (ACOs) have demonstrated early success in cost reduction and quality enhancement. Similarly, countries like Sweden, the Netherlands, and Singapore have incorporated VBHC principles into national health strategies. Pharmaceutical and medical device companies are also embracing value-based agreements that tie reimbursement to real-world effectiveness, rather than unit sales. Employers and insurers are demanding outcome-based care for their covered populations to manage long-term costs. Patient advocacy is growing stronger, demanding transparency, personalized care, and measurable outcomes. Education, trust-building, and data transparency remain crucial for overcoming resistance and establishing value-based frameworks as a norm rather than a niche.

What Is Fueling the Expansive Growth in the Value-Based Healthcare Market?

The growth in the value-based healthcare market is driven by several factors rooted in healthcare system inefficiencies, payer innovations, and changing patient expectations. Rising healthcare expenditures-without proportional gains in patient outcomes-have compelled stakeholders to seek more sustainable, performance-linked care models. The proliferation of chronic illnesses and multimorbidity requires long-term, coordinated care, which is better supported through VBHC frameworks. Increasing adoption of digital health technologies enables accurate measurement of health outcomes and cost metrics, making value-based reimbursement practical. Employers and private payers are advocating for value-based insurance designs that focus on preventive care and long-term health outcomes, thereby driving demand from the payer side. Meanwhile, patients are becoming more involved in their healthcare journeys, expecting cost transparency, treatment efficacy, and personalized experiences-all of which VBHC is structured to deliver. Government reforms and global health initiatives are further institutionalizing value-based approaches through policy support, pilot programs, and international best practice sharing. As these dynamics intensify, VBHC is transitioning from a theoretical model into a dominant paradigm poised to redefine healthcare delivery on a global scale.

SCOPE OF STUDY:

The report analyzes the Value-based Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Models (Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment, Capitation Models); Payer (Medicare & Medicare Advantage, Medicaid, Commercial); Providers (Home Healthcare, Institutional Care, Self-Care, Hospital Therapy)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Aetna Inc.
• Anthem, Inc.
• Athenahealth
• Baker Tilly US, LLP
• Better Health Group
• Blue Cross and Blue Shield of Minnesota
• Cardinal Health
• Change Healthcare
• Cigna Healthcare
• Curation Health
• Deloitte
• Humana
• Kaiser Permanente
• Lumeris
• McKesson Corporation
• MVP Health Care
• Navvis Healthcare
• NXGN Management, LLC
• Signify Health, Inc.
• UnitedHealth Group

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Value-based Healthcare - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Shift from Volume to Outcomes-Based Models Strengthens Business Case for Value-Based Healthcare
  • Emphasis on Patient-Centered Care Expands Addressable Markets for Digital Health Platforms
  • Chronic Disease Management Programs Drive Adoption of Outcome-Oriented Models
  • Government Healthcare Reforms Generate Demand for Quality and Cost Optimization
  • Integration of Wearables and Remote Monitoring Technologies Spurs Real-Time Outcome Tracking
  • Advanced Data Analytics and AI Throw the Spotlight on Predictive Healthcare Solutions
  • Focus on Reducing Hospital Readmissions Sustains Demand for Coordinated Care Models
  • Health Equity and Access Challenges Create Opportunities for Value-Driven Outreach Models
  • Physician Performance and Quality Metrics Enhance Accountability and Propel Payment Shifts
  • Interoperability and Health IT Infrastructure Limitations Pose Adoption Barriers
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Value-based Healthcare Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Value-based Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Value-based Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Value-based Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Pay for Performance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Pay for Performance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Pay for Performance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Patient-centered Medical Home by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Patient-centered Medical Home by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Patient-centered Medical Home by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Shared Savings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Shared Savings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Shared Savings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Shared Risk by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Shared Risk by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Shared Risk by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Bundled Payment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Bundled Payment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Bundled Payment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Capitation Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Capitation Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Capitation Models by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Institutional Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Institutional Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Institutional Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Self-Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Self-Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Self-Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Hospital Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Hospital Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Hospital Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Medicare & Medicare Advantage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Medicare & Medicare Advantage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Medicare & Medicare Advantage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Medicaid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Medicaid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Medicaid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Commercial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Commercial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Commercial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• JAPAN
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• CHINA
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• EUROPE
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Value-based Healthcare by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Value-based Healthcare by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Value-based Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• FRANCE
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 92: France Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• GERMANY
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 119: UK Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Value-based Healthcare by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Value-based Healthcare by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Value-based Healthcare by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• INDIA
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 176: India Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Value-based Healthcare by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Value-based Healthcare by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Value-based Healthcare by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Value-based Healthcare by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Value-based Healthcare by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Value-based Healthcare by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• AFRICA
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030

IV. COMPETITION